DSpace at RU >

Browsing by Author Verweij, J.

Full Text	Issue Date	Title	Author(s)
	2012	A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients	Eechoute, K.; Fransson, M.N.; Reyners, A.K.; de Jong, F.A.; Sparreboom, A., et al
	2011	Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment	Graan, A.J. de; Teunissen, S.F.; Vos, F.Y. de; Loos, W.J.; Schaik, R.H. van, et al
	2010	A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.	Herpen, C.M.L. van; Eskens, F.A.; Jonge, M. de; Desar, I.M.E.; Hooftman, L., et al
	2010	Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.	Hogendoorn, P.C.; Athanasou, N.; Bielack, S.; Alava, E. de; Dei Tos, A.P., et al
	2008	Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity.	Perik, P.J.; Rikhof, B.; Jong, FA de; Verweij, J.; Gietema, J.A., et al
	2006	Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours.	Jonge, M.J.A. de; Dumez, H.; Verweij, J.; Yarkoni, S.; Snyder, D., et al
	2004	[The Dutch Health Council report on palliative chemotherapy: possible confusion on ideas]	Verweij, J.; Mulder, P.H.M. de; Pinedo, H.M.
	1996	Multicentre phase II pharmacological evaluation of rhizoxin	McLeod, H.L.; Murray, L.S.; Wanders, J.; Setanoians, A.; Graham, M.A., et al
	1996	Phase II study rhizoxin in squameus cell head and neck cancer	Verweij, J.; Wanders, J.; Gil, Th.; Schöffski, P.; Catimel, G., et al
	1996	Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained	Wit, R. de; Schmitz, P.I.M.; Verweij, J.; Boer-Dennert, M. de; Mulder, P.H.M. de, et al
	1995	Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group Study	Schornagel, J.H.; Verweij, J.; Mulder, P.H.M. de; Cognetti, F.; Vermorken, J.B., et al
	1995	Phase II studies of docetaxel in the treatment of various solid tumours	Verweij, J.; Catimel, G.; Sulkes, A.; Sternberg, C.N.; Wolff, I., et al
	1995	Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study	Wagener, D.J.T.; Verdonk, H.E.R.; Dirix, L.Y.; Catimel, G.; Siegenthaler, P., et al